Archive:
The Regensburg Tumor Center, founded in 1991, is a neutral and independent quality assurance center with a network of around 1,500 doctors* in Upper Palatinate and Lower Bavaria as well as 50 regional hospitals - including the Regensburg University Hospital. In accordance with the requirements of the Cancer Registry Act, the facility is responsible in its function as an “Institute for Quality Assurance and Health Services Research” for the structured collection and evaluation of the disease data aggregated in the tumor center. The “manager” of this data treasure is private lecturer Monika Klinkhammer-Schalke. The director of the tumor center, who has a doctorate (medicine) and a diploma (theology), and her team of around 30 people would like to draw conclusions about the development and progression of individual cancers and use the resulting findings to further develop the quality of care.
04.06.2018
For nearly two years, an ad-hoc commission of the German Network for Health Services Research (DNVF) has been addressing something that has been lacking in German healthcare, in policy-making, in the executive self-governing bodies, and also in the innovation fund it regulates: objectives. The 6th DNVF Health Services Research Forum, entitled "Healthcare Objectives," demonstrated that dealing with this topic is anything but trivial; in fact, it is highly complex.
04.06.2018
At the "Extrapolation 2018" conference, organized by "Monitor Versorgungsforschung" (MVF) on April 11, 2018, it became clear that while randomized controlled trials (RCTs) were considered by all speakers to be the gold standard for demonstrating effectiveness under ideal conditions, it remains unclear which agreed-upon processes can be used to transfer—or extrapolate—the results obtained in RCTs into real-world healthcare. This provided ample reason to follow this first German-language conference with a scientific symposium entitled "RCT – Bias Control?" The discussion featured PD Dr. Stefan Lange (Deputy Director of the Institute for Quality and Efficiency in Health Care), health economist Prof. Dr. Jürgen Wasem, and Prof. Dr. Franz Porzsolt, founder of clinical economics and the Institute of Clinical Economics (ICE).
04.06.2018
Panel discussion at the 8th “Monitor Health Care Research” specialist congress. Prof. Dr. Thomas Wilke, Dr. Michael Happich, Prof. Dr. Dieter Paar, Dr. Ilona Köster-Steinebach, Corinna Schaefer, Prof. Dr. Reinhold Roski, Prof. Dr. Wolf-Dieter Ludwig, Prof. Dr. Bertram Häussler, Prof. Dr. Matthias Schrappe and Prof. Dr. Gerd Antes.
04.06.2018
Prompted by two very contrasting positions presented at the MVF conference „Extrapolation 2018“ by Prof. Dr. Gerd Antes on the one hand and Prof. Dr. Bertram Häussler on the other, „Monitor Versorgungsforschung“ asked Prof. Dr.-Ing. Thomas P. Zahn to provide a detailed cover interview clarifying terms: from learning systems, through machine learning, to the often and – according to Zahn – unfortunately also too often overused artificial intelligence.
04.06.2018
Comment by Prof. Dr. med. Franz Porzsolt, Chairman of the Board of the Institute of Clinical Economics (ICE)
04.06.2018
Maintaining high-quality medical care, particularly in rural areas, is the goal of IGiB GbR (Innovative Healthcare in Brandenburg). To this end, the consortium, comprised of the Brandenburg Association of Statutory Health Insurance Physicians and the health insurance funds AOK Nordost and BARMER, is developing tailored care models for Brandenburg. One of its most successful projects is the case manager agneszwei. The partners in this start-up joint venture believe that this approach to healthcare should be integrated into everyday practice nationwide.
04.06.2018
Interview with Prof. Dr. Uwe May and Prof. Dr. Jürgen Wasem at the HSK satellite symposium on biosimilars
04.06.2018
The Central Institute for Statutory Health Insurance in the Federal Republic of Germany (Zi) called its congress “Cross-sector remuneration – chimera or soon to be reality?”, at which, among other things, a study by the IGES on “Perspectives of cross-sector remuneration for medical services” was presented.
04.06.2018
„Big Data“ has a major problem: virtually everyone is talking about it, but no one really knows what it is. Two professors who have been working on this overarching topic for many years, albeit in very contrasting ways, and have already spoken publicly about it on several occasions, are Prof. Dr. Gerd Antes, Scientific Director of the German Cochrane Foundation and Co-Director of Cochrane Germany, and Prof. Dr. Bertram Häussler, Chairman of the Board of the IGES Institute. In a debate with „Monitor Versorgungsforschung“ (Health Services Research Monitor), it becomes clear, in addition to fundamental work on definition and delimitation, that this is only the beginning of a difficult but long overdue discussion that urgently needs to be held in Germany, especially in the sensitive context of healthcare.